Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Iovance Biotherapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get IOVA alerts

About James Ziegler

The proxy statement of Geron Corp reports total compensation of $2,392,709 for James Ziegler in fiscal 2025, including a base salary of $470,028. Disclosed compensation is on record for 2 fiscal years. Iovance Biotherapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Iovance Biotherapeutics, Inc. includes Frederick G. Vogt, Ph.D. (CEO), Frederick Vogt (CEO and General Counsel), Corleen Roche (CFO) and 7 others.

Affiliation history

Company network

Leadership on record at Iovance Biotherapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Geron Corp (GERN) $470,028 $2,392,709
2024 Geron Corp (GERN) $163,221 $5,768,744

Recent activity

No call appearances or filed executive changes recorded yet.